Business
Death of Director
Death of Director.
About this update from Concurrent Technologies Plc
[{"type":"text","content":"\n \nRNS Number : 2800Y Concurrent Technologies PLC 08 May 2019 \n\nThis announcement contains inside information\n \n8 May 2019\nConcurrent Technologies Plc\n(the 'Company')\n \nDeath of a Director\n \nIt is with deep regret that Concurrent Technologies Plc (AIM: CNC), announces that Glen Fawcett, CEO, died unexpectedly on 7 May 2019. The Board extends its deepest condolences and sympathies to Glen's family.\n \nJane Annear, Commercial Director, has agreed to act as interim CEO, effective immediately. A further announcement will be made in due course.\n \nEnquiries:\n \n\n\n\nConcurrent Technologies Plc Michael Collins, Chairman\n\n\n \n+44 (0)1206 752626\n\n\n\n\n \n\n\n \n\n\n\n\nNewgate (Financial PR) Bob Huxford\nImogen Humphreys\n\n\n \n+44 (0)20 7653 9848\n+44 (0)20 7653 9840\n\n\n\n\n \n\n\n \n\n\n\n\nCenkos Securities Plc (NOMAD) Neil McDonald\nBeth McKiernan\n\n\n\n+44 (0)131 220 9771\n+44 (0)131 220 9778\n\n\n\n \nNote to Editors:\n \nAbout Concurrent Technologies Plc\n \nConcurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 8th generation Intel® Core™ processors, Intel® Xeon® and Intel® Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.\n \nFor more information on Concurrent Technologies Plc and its products please visit www.gocct.com.\n \nAll trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.\n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. END MSCSSDFMWFU...